Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

US Patent 10287640 · Granted May 14, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Metapneumovirus strains and their use in vaccine formulations and as vectors for2022
Metapneumovirus strains and their use in vaccine formulations and as vectors for2022
Metapneumovirus strains and their use in vaccine formulations and as vectors for2022
Metapneumovirus strains and their use in vaccine formulations and as vectors for2022
Metapneumovirus strains and their use in vaccine formulations and as vectors for2022
Virus causing respiratory tract illness in susceptible mammals2021
Virus causing respiratory tract illness in susceptible mammals2021
Virus causing respiratory tract illness in susceptible mammals2021
Virus causing respiratory tract illness in susceptible mammals2021
Virus causing respiratory tract illness in susceptible mammals2021
Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl pept2020
Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl pept2020